Log In

Lecanemab approval in EU: what should we be ready for?– the EANM perspective

Files

s00259-025-07066-9.pdf (527.61 KB)

Publication date

2025-04

Authors

Yakushev, Igor
Verger, Antoine
Brendel, Matthias
Cecchin, Diego
Fernandez, Pablo Aguiar
Fraioli, Francesco
Grimmer, Timo
Tolboom, NellekeORCID 0000-0002-8005-2833
Traub-Weidinger, Tatjana
Guedj, Eric

Editors

Advisors

Supervisors

DOI

https://doi.org/10.1007/s00259-025-07066-9

Document Type

Editorial

Metadata

Show full item record

Collections

UMC Repository
Open Access logo

License

cc_by

Abstract

Keywords

Radiology Nuclear Medicine and imaging

Citation

Yakushev, I, Verger, A, Brendel, M, Cecchin, D, Fernandez, P A, Fraioli, F, Grimmer, T, Tolboom, N, Traub-Weidinger, T, Guedj, E & Van Weehaeghe, D 2025, 'Lecanemab approval in EU : what should we be ready for?– the EANM perspective', European Journal of Nuclear Medicine and Molecular Imaging, vol. 52, no. 5, pp. 1607-1610. https://doi.org/10.1007/s00259-025-07066-9

URI

http://hdl.handle.net/1874/460618